Close
Back to KZR Stock Lookup

(KZR) – Management Comments

Oct 23, 2020 07:04 AM Kezar Life Sciences (KZR) Granted Orphan Drug Designations for KZR-616 for the Treatment of Polymyositis & Dermatomyositis
Jun 3, 2020 05:36 PM Kezar Life Sciences (KZR) Provides Data Update from MISSION Study of KZR-616 in Patients with SLE

Back to KZR Stock Lookup